Ropivacaine (rINN) (IPA: ) is a local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer. Ropivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Naropin.

History

---

Ropivacaine was developed after bupivacaine was noted to be associated with cardiac arrest in 0.5–0.75% of cases, particularly in pregnant women. Ropivacaine was found to have less cardiotoxicity than bupivacaine in animal models.

Clinical use

---

Indications

Ropivacaine is indicated for local anaesthesia including infiltration, nerve block, epidural and intrathecal anaesthesia in adults and children over 12 years. It is also indicated for peripheral nerve block and caudal epidural in children 1–12 years for surgical pain. It is also sometimes used for infiltration anaesthesia for surgical pain in children.

More on [ Ropivacaine ]

Ropivacaine - Twitter Search

The optimal dose of intrathecal sufentanil to be added to low-dose intrathecal ropivacaine during anesthesia for... http://t.co/VqhcYdpW
AnestesiaF (Anestesia-Fabumed) Thu, 26 Jan 2012 11:23:04 -0000
The optimal dose of intrathecal sufentanil to be added to low-dose intrathecal ropivacaine during anesthesia for... http://t.co/VqhcYdpW
The optimal dose of intrathecal sufentanil to be added to low-dose intrathecal ropivacaine during anesthesia for... http://t.co/X8PGecuc
AnestesiaF (Anestesia-Fabumed) Thu, 26 Jan 2012 11:23:03 -0000
The optimal dose of intrathecal sufentanil to be added to low-dose intrathecal ropivacaine during anesthesia for... http://t.co/X8PGecuc
Ropivacaine RSS feed